Description: Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
Home Page: www.sonomapharma.com
SNOA Technical Analysis
645 Molly Lane
Woodstock,
GA
30189
United States
Phone:
800 759 9305
Officers
| Name | Title |
|---|---|
| Ms. Amy M. Trombly | CEO, Pres & Director |
| Mr. Bruce Thornton | COO & Corp. Sec. |
| Mr. Jerome Dvonch | Exec. Officer |
| Mr. Chad White | Interim Chief Financial Officer |
| Dr. Robert Northey | Exec. VP of R&D |
| Ms. Victoria Covel | Assistant Controller |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6232 |
| Price-to-Sales TTM: | 0.3471 |
| IPO Date: | 2007-01-25 |
| Fiscal Year End: | March |
| Full Time Employees: | 12 |